Health and Medicine (Audio)

AI in healthcare raises urgent questions about bias, privacy, and power. Safiya U. Noble, Ph.D., examines how AI systems can reproduce social and racial inequities when they rely on incomplete data, hidden assumptions, and proxies such as healthcare spending. Noble points to problems in search engines, image generation, facial recognition, and medical algorithms, including cases where systems mislabel darker skin, fail more often on Black women, or favor white patients over sicker Black patients. She also highlights the risks of turning sensitive public and patient data over to large technology companies. Rather than treating AI as a neutral solution, Noble emphasizes the need for human judgment, community participation, stronger data protections, and smaller expert models with local control so healthcare decisions better reflect people’s real lives and social context. Series: "Exploring Ethics" [Health and Medicine] [Humanities] [Science] [Show ID: 41364]

Alzheimer’s disease unfolds over many years through a complex interplay of amyloid, tau, genetics, lipid biology, and the brain’s immune response. John Hardy, Ph.D., explains how rare inherited forms of Alzheimer’s disease helped shape current thinking about how the disease begins, then connects those discoveries to broader questions about late onset disease and why it develops differently across people. Hardy shows that amyloid and tau are linked but not identical, and argues that problems with protein buildup and clearance both matter in understanding the disease. He also emphasizes that Alzheimer’s is not a single event but a long process, which makes prediction, diagnosis, and treatment especially difficult. While current amyloid-targeting therapies can help and show measurable benefit, Hardy says they do not stop the disease, underscoring the need for earlier diagnosis, better treatments, and wider access to care Series: "Shiley Endowed Lecture" [Health and Medicine] [Show ID: 41250]

Seizures caused by epilepsy can have a dramatic impact on one's quality of life. For Nolan, his seizures cost him everyday independence, including the ability to drive. When he decided to have surgery, he chose awake brain surgery led by Dr. Edward Chang, a neurosurgeon at UCSF. During surgery, Nolan speaks and responds as the medical team carefully maps the language regions of his brain — guiding their treatment of him while protecting his ability to communicate. The result opens a path back toward the freedoms Nolan has been missing. [Health and Medicine] [Show ID: 41414]

Cognitive resilience depends on how the brain responds to environment, aging, and inflammation. J. Tiago Gonçalves, Ph.D., studies the hippocampus to examine how spatial memory is shaped by factors such as cognitive enrichment, exercise, social interaction, disease, and age. Gonçalves explains how adult neurogenesis and microglia help support the brain’s ability to encode information, and how disruptions in these systems can affect memory. He also shows that aging and systemic inflammation can weaken spatial encoding while still revealing signs of adaptation and recovery over time. By connecting brain plasticity, immune activity, and memory formation, Gonçalves presents a broader view of how cognition changes across the lifespan and how these mechanisms may inform future strategies for addressing cognitive decline Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 40848]

Alpha Clinics in California accelerate the development of regenerative medicine therapies that use cells and genes to treat serious diseases. Patient advocate Tara Radcliffe Ghiglieri shares lived experience with gene therapy, while Sheldon Morris, M.D., M.P.H., Mehrdad Abedi, M.D., Daniela A. Bota, M.D., Ph.D., Catriona Jamieson, M.D., Ph.D., Michael Lewis, M.D., Mark Walters, M.D., and Leo D. Wang, M.D., Ph.D., describe how Alpha Clinic teams design and deliver clinical trials for a wide range of conditions, including cancer, blood disorders, neurologic disease, osteoarthritis, metabolic disorders, pulmonary arterial hypertension, and Duchenne muscular dystrophy. They highlight how coordinated networks, community partnerships, and genomic tools help expand access, lower financial barriers, and bring promising cell and gene therapies to more patients while carefully tracking safety, effectiveness, and long-term outcomes. Series: "Stem Cell Channel" [Health and Medicine] [Show ID: 41168]